Stephen Jensik to Equivalence Trials as Topic
This is a "connection" page, showing publications Stephen Jensik has written about Equivalence Trials as Topic.
Connection Strength
0.046
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.046
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.